Crinetics Pharmaceuticals, Inc. Financial Ratios — CRNX

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-36.39	-51.64	-42.95	-50.24	-49.98	-32.05	-40.21
Return on Assets (%)	- -	-64.95	-29	-33.42	-47.04	-40.28	-46.62	-43.45	-28.83	-36.34
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	100	100	100	100	86.02
EBITDA Margin (%)	- -	- -	- -	- -	- -	-9,905.38	-3,523.31	-5,519.81	-32,345.43	-6,664.23
Operating Margin (%)	- -	- -	- -	- -	- -	-9,990.91	-3,544.06	-5,547.17	-32,613.47	-6,714.77
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	-9,985.25	-3,460.38	-5,345.85	-28,720.69	-6,043.88
Profit Margin (%)	- -	- -	- -	- -	- -	-9,985.25	-3,460.38	-5,345.85	-28,720.69	-6,046.22
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	-9,985.25	-3,460.38	-5,345.85	-28,720.69	-6,046.22
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-36.39	-51.64	-42.95	-50.24	-49.98	-32.05	-40.21

Credit (USD)

MCP API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	5	4	3	3	52	52	49
ST Debt	- -	- -	- -	- -	- -	- -	1	4	7	6
LT Debt	- -	- -	- -	5	4	3	2	48	45	42
Total Debt/EBITDA	-0.04	- -	- -	-0.09	-0.05	-0.03	-0.02	-0.23	-0.15	-0.09
Net Debt/EBITDA	2.01	1.58	1.59	0.76	1.26	1.88	0.2	0.25	0.79	0.2
Total Debt/EBIT	-0.04	- -	- -	-0.09	-0.05	-0.03	-0.02	-0.23	-0.15	-0.09
Net Debt/EBIT	1.98	1.55	1.57	0.75	1.24	1.86	0.19	0.25	0.78	0.2
EBITDA to Interest Expense	-541.09	-1,124.88	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-558.36	-1,162.88	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	-549.45	-1,140.88	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-56.41	-104.27	93.44	89.73	92.07	94.68	90.94	84.7	92.28	87.93
Long-Term Debt/Equity (%)	- -	- -	- -	4.14	2.38	0.93	0.64	8.82	3.36	4.24
Long-Term Debt/Capital (%)	-2.36	- -	- -	3.98	2.32	0.92	0.63	8.06	3.24	4.05
Long-Term Debt/Total Assets (%)	1.29	- -	- -	3.72	2.19	0.88	0.57	7.48	3.11	3.73
Total Debt/Equity (%)	-3.42	- -	- -	4.14	2.38	0.93	0.97	9.6	3.9	4.89
Total Debt/Capital (%)	-3.07	- -	- -	3.98	2.32	0.92	0.95	8.77	3.76	4.67
Total Debt/Total Assets (%)	1.68	- -	- -	3.72	2.19	0.88	0.87	8.14	3.61	4.31
Net Debt to Equity	192.46	94.47	-28.07	-34.43	-55.11	-60.46	-10.33	-10.18	-19.97	-10.23
Net Debt/Capital (%)	62.69	46.6	-39.04	-49.47	-116.62	-148.99	-11.24	-10.26	-23.81	-10.83
EBITDA	-6	-9	-28	-53	-74	-107	-167	-222	-336	-513
EBITDA-CapEx	-6	-9	-29	-53	-74	-107	-169	-226	-340	-519
Operating Income (Loss)	-6	-9	-29	-54	-75	-108	-168	-223	-339	-517

Liquidity (USD)

MCP API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	13.65	15.82	20.68	14.2	16.29	20.86	12.06	12.71	22.69	12.08
Current Ratio	13.89	16.91	21.03	14.79	16.92	21.55	12.45	13.07	23.04	12.32
Quick Ratio	13.73	16.64	20.92	14.33	16.47	20.99	12.17	12.92	22.69	12.09
CFO/Avg Current Liab	- -	-10.61	-4.41	-5.7	-6.59	-6.69	-5.27	-4.71	-4.44	-5.22
Common Equity/Total Assets	-56.41	-104.27	93.44	89.73	92.07	94.68	90.94	84.7	92.28	87.93
Long-Term Debt/Equity (%)	- -	- -	- -	4.14	2.38	0.93	0.64	8.82	3.36	4.24
Long-Term Debt/Capital (%)	-2.36	- -	- -	3.98	2.32	0.92	0.63	8.06	3.24	4.05
Long-Term Debt/Total Assets (%)	1.29	- -	- -	3.72	2.19	0.88	0.57	7.48	3.11	3.73
Total Debt/Equity (%)	-3.42	- -	- -	4.14	2.38	0.93	0.97	9.6	3.9	4.89
Total Debt/Capital (%)	-3.07	- -	- -	3.98	2.32	0.92	0.95	8.77	3.76	4.67
Total Debt/Total Assets (%)	1.68	- -	- -	3.72	2.19	0.88	0.87	8.14	3.61	4.31
CFO/Total Liabilities	-29.08	-30.96	-173.9	-350.36	-427.01	-464.52	-321.37	-175.17	-209.67	-281.67
CFO/CapEx	-28.78	-31.18	-18.37	-94.27	-333.48	-203.18	-69.57	-35.96	-59.88	-65.59
Altman's Z-Score	-1.28	-2.29	19.73	26.18	16.21	33.37	13.7	11.29	21.97	17.34

Working Capital (USD)

MCP API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	26
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.04
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.06
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	342.95
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.22
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,676.79
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,319.8
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	-328.91
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	2
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	2

Enterprise Value (USD)

MCP API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	364	607	430	1,092	951	2,066	4,130	4,378
- Cash & Cash Equivalents	12	14	45	40	93	201	33	55	265	102
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	5	4	3	3	52	52	49
Enterprise Value	-12	-14	200	493	263	761	620	1,559	2,828	3,399
Total Capital	-7	-16	160	122	173	335	323	590	1,376	1,039
Total Debt/Capital (%)	-3.07	- -	- -	3.98	2.32	0.92	0.95	8.77	3.76	4.67
Total Debt / EV	-0.02	- -	- -	0.01	0.02	- -	- -	0.03	0.02	0.01
EV/Sales	- -	- -	- -	- -	- -	706.25	130.87	388.57	2,721.93	441.66
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	364	607	430	1,092	951	2,066	4,130	4,378
Diluted Enterprise Value	-12	-14	319	571	341	894	922	2,063	3,918	4,325
EV per Share	- -	- -	16.49	20.39	8.63	19.81	11.93	26.85	35.01	36.14
TTM Sales	- -	- -	- -	- -	- -	1	5	4	1	8
TTM EBITDA	-6	-9	-28	-53	-74	-107	-167	-222	-336	-513
TTM Operating Income	-6	-9	-29	-54	-75	-108	-168	-223	-339	-517
TTM Cash Flow to Firm	-5	-9	-19	-46	-62	-89	-115	-169	-230	-378
TTM Free Cash Flow to Firm	-5	-9	-18	-46	-62	-88	-114	-164	-226	-372

Multiples (USD)

MCP API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-19.79	-13.22	-6.95	-12.39	-8.38	-12.61	-18.25	-11.76
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-12	-14	200	493	263	761	620	1,559	2,828	3,399
Low Price	- -	- -	19.23	14.33	10.63	13.29	15.37	15.23	33.67	24.1
EV/Sales	- -	- -	- -	- -	- -	706.25	130.87	388.57	2,721.93	441.66
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-12.92	-10.51	-6.87	-7.04	-6.2	-6.08	-13.08	-7.32
Price/Earnings High	- -	- -	-18.81	-14.67	-11	-10.29	-9.18	-10.25	-16.93	-10.82
Price/Earnings Low	- -	- -	-8.61	-6.87	-4.38	-4.75	-4.87	-4.12	-9.11	-4.87
Price/Book Value	- -	- -	2.27	5.18	2.54	3.29	2.97	3.84	3.12	4.42
Price/Book Value Average	- -	- -	2.19	4.53	3	2.28	3.17	2.42	2.95	3.44
Price/Book Value High	- -	- -	3.18	6.32	4.81	3.33	4.7	4.09	3.82	5.09
Price/Book Value Low	- -	- -	1.46	2.96	1.92	1.54	2.49	1.64	2.05	2.29
Price/Tangible Book Value	- -	- -	2.27	5.18	2.54	3.29	3.01	3.83	3.12	4.41
Price/Tangible Book Value Average	- -	- -	2.19	4.52	3	2.28	3.21	2.42	2.95	3.43
Price/Tangible Book Value High	- -	- -	3.18	6.32	4.81	3.34	4.76	4.08	3.81	5.08
Price/Tangible Book Value Low	- -	- -	1.46	2.96	1.92	1.54	2.53	1.64	2.05	2.28
Price/Sales	- -	- -	- -	- -	- -	1,012.96	200.82	514.87	3,975.39	568.91
Price/Sales Average	- -	- -	- -	- -	- -	703.06	214.56	324.95	3,757.2	442.47
Price/Sales High	- -	- -	- -	- -	- -	1,027.57	317.69	548.15	4,861.75	654.46
Price/Sales Low	- -	- -	- -	- -	- -	473.85	168.66	220.39	2,617.87	294.54
Price/Cash Flow	- -	- -	-18.71	-13.08	-6.93	-12.33	-8.26	-12.25	-17.94	-11.59
Price/Cash Flow Average	- -	- -	-18	-11.42	-8.18	-8.56	-8.82	-7.73	-16.96	-9.01
Price/Cash Flow High	- -	- -	-26.21	-15.95	-13.09	-12.5	-13.06	-13.05	-21.94	-13.33
Price/Cash Flow Low	- -	- -	-12	-7.47	-5.22	-5.77	-6.94	-5.25	-11.82	-6
Price/Free Cash Flow Average	- -	- -	-19.03	-11.54	-8.2	-8.6	-8.95	-7.96	-17.25	-9.15
Price/Free Cash Flow High	- -	- -	-27.72	-16.12	-13.13	-12.57	-13.25	-13.42	-22.32	-13.53
Price/Free Cash Flow Low	- -	- -	-12.69	-7.55	-5.23	-5.79	-7.04	-5.4	-12.02	-6.09
EV/Sales Average	- -	- -	- -	- -	- -	519.74	208.31	324.16	3,552.37	435.59
EV/Sales High	- -	- -	- -	- -	- -	844.25	311.44	547.36	4,656.92	647.58
EV/Sales Low	- -	- -	- -	- -	- -	290.53	162.42	219.6	2,413.03	287.65
EV/EBITDA Average	2.01	1.58	-10.81	-9.34	-5.65	-5.25	-5.91	-5.87	-10.98	-6.54
EV/EBITDA High	2.01	1.58	-16.47	-13.31	-9.77	-8.52	-8.84	-9.92	-14.4	-9.72
EV/EBITDA Low	2.01	1.58	-6.68	-5.87	-3.17	-2.93	-4.61	-3.98	-7.46	-4.32
EV/EBIT Average	1.98	1.55	-10.63	-9.18	-5.58	-5.2	-5.88	-5.84	-10.89	-6.49
EV/EBIT High	1.98	1.55	-16.2	-13.09	-9.65	-8.45	-8.79	-9.87	-14.28	-9.64
EV/EBIT Low	1.98	1.55	-6.57	-5.78	-3.13	-2.91	-4.58	-3.96	-7.4	-4.28
Last Price	- -	- -	29.99	25.09	14.11	28.41	18.3	35.58	51.13	46.55
High Price	- -	- -	42	30.61	26.67	28.82	28.95	37.88	62.53	53.55
Enterprise Value Average	-12	-14	305	494	418	560	987	1,301	3,691	3,352
Enterprise Value High	-12	-14	465	704	723	910	1,475	2,197	4,839	4,984
Enterprise Value Low	-12	-14	189	311	235	313	769	881	2,507	2,214

Shares Outstanding	22	22	24	24	33	48	54	68	93	96
Diluted Weighted Avg Shares	14	14	12	24	30	38	52	58	81	94
Basic Weighted Avg Shares	14	14	12	24	30	38	52	58	81	94
Revenue per Share	- -	- -	- -	- -	- -	0.03	0.09	0.07	0.01	0.08
EBITDA per Share	-0.43	-0.65	-2.33	-2.19	-2.43	-2.78	-3.21	-3.81	-4.16	-5.45
Operating Income per Share	-0.44	-0.66	-2.36	-2.23	-2.46	-2.8	-3.23	-3.83	-4.19	-5.49
Basic EPS, GAAP	-0.43	-0.66	-2.23	-2.09	-2.42	-2.8	-3.15	-3.69	-3.69	-4.95
Basic EPS from Cont Ops	-0.43	-0.66	-2.23	-2.09	-2.42	-2.8	-3.15	-3.69	-3.69	-4.95
Diluted EPS, GAAP	-0.43	-0.66	-2.23	-2.09	-2.42	-2.8	-3.15	-3.69	-3.69	-4.95
Diluted EPS from Cont Ops	-0.43	-0.66	-2.23	-2.09	-2.42	-2.8	-3.15	-3.69	-3.69	-4.95
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.39	-0.68	-1.6	-1.92	-2.04	-2.3	-2.22	-2.9	-2.85	-4.02
Free Cash Flow per Basic Share	-0.41	-0.7	-1.69	-1.94	-2.04	-2.32	-2.25	-2.98	-2.9	-4.08
Cash & Equivalents per Share	0.88	1.02	13.5	4.9	5.61	8.68	6.43	9.62	16.76	10.93
Book Value per Share	-0.51	-1.17	13.19	4.84	5.55	8.65	6.16	9.27	16.39	10.53
Tangible Book Value per Share	-0.45	-1.08	13.2	4.85	5.55	8.64	6.09	9.28	16.4	10.55

Crinetics Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)